Fundraising Fox

Daniel S. Lorrain

Chief Scientific Officer at Contineum Therapeutics

San Diego, California, United States

Find your path to Daniel

Chief Scientific Officer at Contineum Therapeutics

Intro paths

→

In turn, Daniel can intro founders to Contineum Therapeutics's investors below.

Contineum Therapeutics's investors · 8

Casdin CapitalNew YorkFranklin TempletonSan MateoHadean VenturesOsloJJDCNew Brunswick · $500K – $5M checksRed Tree VentureSan DiegoSamsara BioCapitalPalo AltoSectoral Asset ManagementMontrealVersant VenturesSan Francisco · $250K – $5M checks

Experience

  1. Contineum TherapeuticsChief Scientific Officer2024 — 2026San Diego, CA
  2. Contineum TherapeuticsChief Scientific Officer2017 — 2024
  3. Inception Sciences, Inc.Vice President, Biology2016 — 2018Greater San Diego Area
  4. Inception Sciences, Inc.Executive Director, Head of Biology2011 — 2016San Diego
  5. Amira PharmaceuticalsSenior Director, Pharmacology2005 — 2011
  6. MerckResearch Fellow, Pharmacology1999 — 2005San Diego
  7. The University of ChicagoPostdoc1997 — 1999

Skills & more

Pharmacology18Biology12Drug Discovery15Drug Development8Lifesciences3Clinical Development4In Vitro2Biotechnology3Pharmacokinetics1Pharmaceutical Industry4Medicinal Chemistry1High Throughput Screening1
+8 moreLead ChangeADMEOncologyDMPKHPLCDrug DesignIn VivoAssay Development

From Daniel's professional profile.

Frequently asked questions

Who is Daniel S. Lorrain?
Chief Scientific Officer at Contineum Therapeutics
Where does Daniel S. Lorrain work?
Daniel S. Lorrain is Chief Scientific Officer at Contineum Therapeutics.
Where did Daniel S. Lorrain go to school?
Daniel S. Lorrain studied at University of Chicago (Post Doc, Department of Psychiatry and Behavioral Neuroscience); University at Buffalo (Doctor of Philosophy (PhD), Behavioral Neuroscience); University at Buffalo (Bachelor's degree, Psychology).

Same school

Also attended University of Chicago599

Mark SusterManaging Partner at Upfront VenturesShardul ShahInvestor at Index VenturesSam BlackmanEntrepreneur in Residence at GV (Google Ventures)Clay FisherInvestor at Spark CapitalRolanda FuInvestor at Madrona Venture GroupJonas CiplickasPrincipal at Scale Venture Partners

+ 593 more

Also attended University at Buffalo158

Ariel LebowitsCFO at FJ LabsRyan ScottInvestor at Khosla VenturesMichael TaylorOperating Partner at Mission BiocapitalLinda SinghInvestor at Golden SeedsBrian KangCo-Founder & Managing Director at Nautilus Ventures Management Company (Us), LlcKenneth K ThomasPrincipal at Backfuture Ventures, Llc

+ 152 more

Shared employers

Also worked at Contineum Therapeutics4

Asish K. XavierVice President, Venture Investments at JJDCFrançois BeaubienPartner at Sectoral Asset ManagementEef SchimmelpenninkFounder at LenzTroy IgnelziExecutive Officer at Juventas Therapeutics

Also worked at Amira Pharmaceuticals3

Brian FarmerEntrepreneur-in-Residence at Frazier Life SciencesBob BalteraSenior Advisor at Frazier Life SciencesHeath LukatchPartner at Novo Holdings

Also worked at Merck260

Anika GuptaInvestor at GV (Google Ventures)Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Catherine Pearce, DHSc, MBAAdvisor at CincyTechDavid MollerInvestor at Third Rock VenturesAlan EzekowitzInvestor at Third Rock VenturesUri LopatinInvestor at Khosla Ventures

+ 254 more

Also worked at The University of Chicago127

Sarika Temme-BapatVenture Operations Associate at Mission BiocapitalCorey RitterPartner at ARCH Venture PartnersPeter MintunAssociate at ARCH Venture PartnersGordon RausserAdvisory Board Member at Rembrandt Venture PartnersMira ChaurushiyaManaging Director at Westlake Village BioPartnersIsha MehrotraAssociate at Uncork Capital

+ 121 more